-

$undefined

N/A

(N/A)

ENVERIC BIOSCIENCES INC NASDAQ:ENVB Enveric Biosciences is a patient-first biotechnology company developing rigorously tested, novel cannabinoid medicines to improve quality of life for cancer patients. Initial indications include radiodermatitis, a common and often severe side effect of radiation therapy, and chemotherapy-induced neuropathy.

Location: 5000 Research Ct Ste 750, Georgia, 30024-6608, US | Website: www.enveric.com | Industry: Semiconductor and Related Device Manufacturing | Sector: Manufacturing

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

1.281M

Cash

3.503M

Avg Qtr Burn

-2.495M

Short % of Float

2.31%

Insider Ownership

7.72%

Institutional Own.

5.67%

Qtr Updated

06/30/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date